Navigation Links
Chemotherapy causes delayed severe neural damage
Date:4/21/2008

Cancer treatment with chemotherapeutic agents is often associated with delayed adverse neurological consequences - an occurrence often referred to as chemobrain - that may compromise the quality of life of a proportion of cancer survivors. Now, research published in the open access Journal of Biology demonstrates that treatment with a single chemotherapeutic agent, 5-fluorouracil (5-FU), by itself is sufficient to cause a syndrome of delayed degeneration in the central nervous system (CNS). 5-FU is a widely used chemotherapeutic agent that is employed, alone or in combination with other agents, in the treatment of cancers of the colon, rectum, breast, stomach, pancreas, ovaries and bladder.

Little is known about the side-effects of chemotherapy on the CNS, despite their obvious clinical importance. Until now researchers have not fully understood the underlying biology, including whether these effects require: exposure to multiple chemotherapeutic agents; chemotherapeutic agents plus the bodys own response to cancer; blood-brain barrier damage; or inflammation. Clinicians have also lacked animal models to study this important problem.

Professor Mark Noble and colleagues of the University of Rochester Stem Cell and Regenerative Medicine Institute and the Harvard Medical School, Boston discovered that short-term systemic administration of 5-FU to mice caused both acute CNS damage and a syndrome of progressively worsening delayed damage. This damage was not self-repairing, and instead became worse over time. In addition, Noble and colleagues also demonstrated that treatment with chemotherapy also had delayed effects on the speed with which information is transferred from the ear to the brain.

Myelin sheaths are necessary for normal neuronal function. One key finding of the study was that clinically relevant concentrations of 5-FU were toxic not only for dividing cells of the CNS but also for the cells that produce the insulating myelin sh
'/>"/>

Contact: Charlotte Webber
charlotte.webber@biomedcentral.com
44-020-763-19980
BioMed Central
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Chemotherapy may be culprit for fatigue in breast cancer survivors
2. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
3. To evade chemotherapy, some cancer cells mimic stem cells
4. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
5. PET scans can accurately detect a breast tumors response to chemotherapy
6. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
7. Medicare modernization act did not change chemotherapy as feared
8. HER-2 status predicts success of chemotherapy in breast cancer treatment, study finds
9. Cancer conflict with chemotherapy treatment
10. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
11. Jefferson researchers show chemotherapy and radiation together extend lung cancer patients lives

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., PALO ALTO, Calif., Dec. 4 /PRNewswire-FirstCa...nced today that its Board of Directors has set the...ebruary 11, 2010 with a record date of December 16...za Cabana Hotel, 4290 El Camino Real, Palo Alto, C...be webcast by Thomson Financial and can be accesse...
(Date:12/4/2009)...YORK, Dec. 4 Care Inves...ompany") today announced that its Board of Directo...ommon stock. The dividend is payable on December ...ber 14, 2009. ,, About Care Investment Trus...te investment and finance company investing in hea...
(Date:12/4/2009)...EW YORK, Dec. 4 Thousands of KPMG ...s nationwide today, to participate in a community ...visory firm,s support for literacy with charitable...s our firm,s long history of volunteerism. Instead... spirit of caring to brighten the holidays for som...
(Date:12/4/2009)...N FRANCISCO, Dec. 4 Medithrive, In...ite dispensary in the SF Bay Area by popular vote .... Despite only three months in operation, the SF ...inent location for accessing medicinal marijuana. ...e confirms the obvious: a dispensary which caters ...
(Date:12/4/2009)... PEMBROKE, Bermuda, Dec. 4 /PRNewswire-FirstCall...(NYSE: AWH ) today announced that Scott Carmilan... Sennott, Executive Vice,President and Chief Corpo...009,Goldman Sachs U.S. Financial Services Conferen...er in New York City on Tuesday, December 8, 2009. ...
Breaking Medicine News(10 mins):Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
...arch presented at Digestive Disease Week 2005, ant...l bleedings. Clinical depression, also known ...depressant drugs like selective serotonin reuptake...leeding and hemorrhage in gastro intestinal tracts...
...rom Wake Forest University Baptist Medical Center,...orks equally well for children with cancer, and th... The researchers had looked into the chemothe...ery limited dosage of chemotherapy and were monito...
...ering from Attention Deficit Hyperactivity Syndrom...n with the help of sensory interventions like appl...us exercise, etc. Attention Deficit Hyperacti...to be impulsive, inattentive and hyperactive. Rece...
...ave identified a virus that targets and kills a ty...omatitis virus (VSV) can successfully target and k...rms of brain tumors. Glioblastoma is a form of bra...viruses through a series of tests to find out the ...
...rom Netherlands have found out that certain ordina...l drugs can cause deaths from cardiac arrest. ...n Heart Journal, said that the non-cardiac drugs i...rolong the duration of electrical activity that co...
... report done by Swedish scientists its said that i...ge of prostate cancer than to wait and see if the ...tate cancer, also known as prostatectomy, is a com...watching and waiting the cancer in the prostate gl...
Other Medicine News:
(Date:12/4/2009)...RISTOWN, N.J., Dec. 4 Wa...ng global specialty pharmaceutical company, today ..., Inc.-Florida, filed an Abbreviated New Drug Appl...tration seeking approval to market its 8mg ramelte...ed by Takeda Pharmaceutical Company Limited. Wats...
(Date:12/4/2009)...SDA, Md., Dec. 4 Drs. Neal Shore a...e-specific antigen (PSA) recurrence from the addit...cal recurrence rate in a Phase III pivotal study o... or monthly leuprolide in prostate cancer patients...cer patients who received FIRMAGON 240/80 mg/month...
(Date:12/4/2009)...INGTON, Del., Dec. 4 Ast...S Food and Drug Administration (FDA) has approved ... Extended Release Tablets as adjunctive (add-on) t...epressive Disorder (MDD). SEROQUEL XR is the only ...at both major depressive disorder as adjunctive th...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Price Chopper Supermarkets Deploy Micromedex Solutions From Thomson Reuters as Key Component of Its Patient Centered Care Initiatives 53960 1Price Chopper Supermarkets Deploy Micromedex Solutions From Thomson Reuters as Key Component of Its Patient Centered Care Initiatives 53960 2Steroid Can Ease Severe Sore Throat 53956 1Steroid Can Ease Severe Sore Throat 53956 2Steroid Can Ease Severe Sore Throat 53956 3Allscripts Notified of Purported Class Action Lawsuit 53952 1Allscripts Notified of Purported Class Action Lawsuit 53952 2Allscripts Notified of Purported Class Action Lawsuit 53952 3
...Pharmaceuticals, a division of Wyeth (NYSE: WYE )...INvestigation of TORISEL and Avastin,Combination T... phase 3b,study comparing TORISEL(R) (temsirolimus...s interferon-alfa for first-line treatment of pati...th Research is conducting the,INTORACT study with ...
... Important Factor When Selecting Treatment ... - ABSTRACT No: 5110 (Poster 6H), BASEL, S...oncology meeting in the world, the American Societ...s of managing side effects in patients,with metast...ib (Sutent(R)),are two to three times greater than...
Other Medicine Technology:Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 2Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 3Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 4Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 5Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 6Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 2Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 3
Tumbling E Pad(100 sheets) BCE
...riced 2-channel data acquisition system suitable f...n and animal physiology, pharmacology, neurophysio...l engineering. The PowerLab 2/25 supports all ADIn... Pod ports are featured allowing direct connection...
... data acquisition system suitable for a wide range...al physiology, pharmacology, neurophysiology, biol...ring. The unit is capable of recording from very s... second continuously to disk), and is compatible w...
Worth 4 Dot Test
Medicine Products: